IOM: Cancer Care System in Crisis
Care for oncology patients is not as patient-centered, accessible, coordinated, or as evidence-based as it could be, an Institute of Medicine report concludes.
The nation's cancer care delivery system is in disastrous shape because of poor quality measures, rising costs, an insufficiently trained workforce, treatments that don't work, poor clinician-patient communication, deficient palliative care support and the need for much better evidence of what types of patients will benefit.
Those are some of the conclusions from the Institute of Medicine's second major report on cancer care, "Delivering High-Quality Cancer Care, Charting a New Course for a System in Crisis."
"We found that cancer care is not as patient-centered, accessible, coordinated, or as evidence-based as it could be," said Patricia Ganz, MD, chair of the committee that wrote the report and an oncology specialist at UCLA School of Medicine and School of Public Health, during a teleconference Tuesday.
The system is "poorly prepared to meet the needs of" an estimated 1.6 million people diagnosed with cancer annually, in part because clinical trials of chemotherapy drugs almost always enroll people without other comorbid conditions. "The distribution (of who gets certain kinds of cancer) does not look like the population that actually has the disease."
- How Top-Ranked MA Plans Earn Their Stars
- Readmissions: No Quick Fix to Costly Hospital Challenge
- How Hospitals Can Become 'Upstreamists'
- 4 Ways to Lower the Cost to Collect from Self-Pay Patients
- WellPoint Dominates Nearly Half of Markets, AMA Says
- 4 Tips for Managing Employed Physicians
- CMS Offers Some ACOs $114M for 'Upfront' Costs
- House Calls Key to Pioneer ACO Success
- Ebola: Second TX Nurse Diagnosed After Improper Protective Gear Application
- How Telehealth Pays Off for Providers, Patients